Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Uncover various ways to increase your retirement savings after 40, ensuring you maximize your growth potential for the future.
21,993 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A major fund reshaped its Workiva stake in a recent SEC filing, signaling routine portfolio rebalancing rather than a...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Marvell Technology is set to report fiscal Q1 results after the close, with investors weighing AI demand, margins and...
Dell Technologies beats expectations, validating its AI-focused partnership with Palantir and sending Palantir shares...
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
Movement pivots from a speculative token project to a Layer 1 blockchain, backed by Circle and other partners, as it ...
Meta Platforms stock crushed the market today as Meta rolled out a business-focused AI tool worldwide. Investors weig...
This morning’s update centers on a massive Zcash exploit found by a security researcher. The flaw may have lingered f...
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
XRP nears a critical support area that traders call a buying opportunity. Analysts outline a potential rebound to $3 ...
Casey's General Stores stock jumped after a robust earnings report that topped expectations. This guide breaks down w...